Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2016

Open Access 01-12-2016 | Review

Rare disease landscape in Brazil: report of a successful experience in inborn errors of metabolism

Authors: Roberto Giugliani, Filippo P. Vairo, Mariluce Riegel, Carolina F. M. de Souza, Ida V. D. Schwartz, Sérgio D. J. Pena

Published in: Orphanet Journal of Rare Diseases | Issue 1/2016

Login to get access

Abstract

Brazil is a country of continental dimensions, with many social inequalities. The latter are reflected on its health system, which comprises a large public component called SUS, a small paid health insurance component and a third very small private component, in which patients pay personally for medical services. Seventy five percent of the population depends on SUS, which thus far does not provide adequate coverage for genetic medical procedures. In 2014, SUS introduced the “Policy for the Integral Attention to Subjects with Rare Diseases”, establishing guidelines for offering diagnosis and treatment. The policy defines the two main axes, genetic and non-genetic rare diseases. In this fashion, public genetic services in SUS will be installed and funded not by themselves, but as part of the more general policy of rare diseases. Unfortunately, up to now this policy is still depending on financial allowances to be effectively launched. In this article, our intention was to describe activities developed in the area of inborn errors of metabolism by a Brazilian reference center. In spite of the lack of support of SUS, thousands of Brazilian families affected by rare genetic metabolic disorders, and many health professionals from all regions of Brazil, already have benefited from the services, training programs and research projects provided by this comprehensive center.
Literature
1.
go back to reference Baldo G et al. Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-L-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice. Cytotherapy. 2012;14(7):860–7.CrossRefPubMed Baldo G et al. Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-L-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice. Cytotherapy. 2012;14(7):860–7.CrossRefPubMed
2.
go back to reference Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement. Rare Dis. 2013;1:e23579.CrossRefPubMedPubMedCentral Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement. Rare Dis. 2013;1:e23579.CrossRefPubMedPubMedCentral
3.
go back to reference Biancini GB et al. DNA damage in Fabry patients: An investigation of oxidative damage and repair. Mutat Res Genet Toxicol Environ Mutagen. 2015;784–785:31–6.CrossRefPubMed Biancini GB et al. DNA damage in Fabry patients: An investigation of oxidative damage and repair. Mutat Res Genet Toxicol Environ Mutagen. 2015;784–785:31–6.CrossRefPubMed
4.
go back to reference Brustolin S et al. Assessment of a pioneer metabolic information service in Brazil. Community Genet. 2006;9(2):127–32.PubMed Brustolin S et al. Assessment of a pioneer metabolic information service in Brazil. Community Genet. 2006;9(2):127–32.PubMed
5.
go back to reference Camelier M et al. Extended use of dried-leukocytes impregnated in filter paper samples for detection of Pompe, Gaucher, and Morquio A diseases. Clin Chim Acta. 2015;446:218–20.CrossRefPubMed Camelier M et al. Extended use of dried-leukocytes impregnated in filter paper samples for detection of Pompe, Gaucher, and Morquio A diseases. Clin Chim Acta. 2015;446:218–20.CrossRefPubMed
6.
go back to reference Costa-Motta FM et al. Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil. Mol Genet Metab. 2011;104(4):603–7.CrossRefPubMed Costa-Motta FM et al. Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil. Mol Genet Metab. 2011;104(4):603–7.CrossRefPubMed
7.
go back to reference De Souza KR et al. Cytogenomic Evaluation of Subjects with Syndromic and Nonsyndromic Conotruncal Heart Defects. Biomed Res Int. 2015;2015:401941.PubMedPubMedCentral De Souza KR et al. Cytogenomic Evaluation of Subjects with Syndromic and Nonsyndromic Conotruncal Heart Defects. Biomed Res Int. 2015;2015:401941.PubMedPubMedCentral
8.
go back to reference Emy Dorfman L et al. Microarray-based comparative genomic hybridization analysis in neonates with congenital anomalies: detection of chromosomal imbalances. J Pediatr (Rio J). 2015;91(1):59–67.CrossRef Emy Dorfman L et al. Microarray-based comparative genomic hybridization analysis in neonates with congenital anomalies: detection of chromosomal imbalances. J Pediatr (Rio J). 2015;91(1):59–67.CrossRef
9.
go back to reference Giugliani R et al. MPS Brazil Network: An efficient tool to identify MPS patients country-wide. Mol Genet Metab. 2013;108(2):2.CrossRef Giugliani R et al. MPS Brazil Network: An efficient tool to identify MPS patients country-wide. Mol Genet Metab. 2013;108(2):2.CrossRef
10.
go back to reference Lorenzoni PJ et al. Niemann-Pick disease type C: a case series of Brazilian patients. Arq Neuropsiquiatr. 2014;72(3):214–8.CrossRefPubMed Lorenzoni PJ et al. Niemann-Pick disease type C: a case series of Brazilian patients. Arq Neuropsiquiatr. 2014;72(3):214–8.CrossRefPubMed
11.
go back to reference Michelin K et al. Application of a comprehensive protocol for the identification of Gaucher disease in Brazil. Am J Med Genet A. 2005;136(1):58–62.CrossRefPubMed Michelin K et al. Application of a comprehensive protocol for the identification of Gaucher disease in Brazil. Am J Med Genet A. 2005;136(1):58–62.CrossRefPubMed
12.
go back to reference Paim J et al. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377(9779):1778–97.CrossRefPubMed Paim J et al. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377(9779):1778–97.CrossRefPubMed
13.
go back to reference Pasqualim G et al. Fabry disease: a new approach for the screening of females in high-risk groups. Clin Biochem. 2014;47(7–8):657–62.CrossRefPubMed Pasqualim G et al. Fabry disease: a new approach for the screening of females in high-risk groups. Clin Biochem. 2014;47(7–8):657–62.CrossRefPubMed
15.
go back to reference União D. O. D. Section 1. Diário Oficial da União. 2014;30:44–55. União D. O. D. Section 1. Diário Oficial da União. 2014;30:44–55.
16.
go back to reference Valcarenghi A. Pacientes com doenças raras terão acompanhamento a distância no tratamento. Agência Brasil: Brasília, Distrito Federal, Brazil: Empresa Brasil de Comunicação S/A; 2014. Valcarenghi A. Pacientes com doenças raras terão acompanhamento a distância no tratamento. Agência Brasil: Brasília, Distrito Federal, Brazil: Empresa Brasil de Comunicação S/A; 2014.
17.
go back to reference Vieira TA et al. Inclusion of medical genetics in primary health care: report of a pilot project in Brazil. J Community Genet. 2013;4(1):137–45.CrossRefPubMed Vieira TA et al. Inclusion of medical genetics in primary health care: report of a pilot project in Brazil. J Community Genet. 2013;4(1):137–45.CrossRefPubMed
18.
go back to reference Wajner M, Coelho Dde M, Ingrassia R, de Oliveira AB, Busanello EN, Raymond K, Flores Pires R, de Souza CF, Giugliani R, Vargas CR. Selective screening for organic acidemias by urine organic acid GC-MS analysis in Brazil: fifteen-year experience. Clin Chim Acta. 2009;400(1-2):77–81. Wajner M, Coelho Dde M, Ingrassia R, de Oliveira AB, Busanello EN, Raymond K, Flores Pires R, de Souza CF, Giugliani R, Vargas CR. Selective screening for organic acidemias by urine organic acid GC-MS analysis in Brazil: fifteen-year experience. Clin Chim Acta. 2009;400(1-2):77–81.
Metadata
Title
Rare disease landscape in Brazil: report of a successful experience in inborn errors of metabolism
Authors
Roberto Giugliani
Filippo P. Vairo
Mariluce Riegel
Carolina F. M. de Souza
Ida V. D. Schwartz
Sérgio D. J. Pena
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2016
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-016-0458-3

Other articles of this Issue 1/2016

Orphanet Journal of Rare Diseases 1/2016 Go to the issue